COSMO Pharmaceuticals SA Asset Resilience Ratio

Latest as of December 2025: 10.92%

COSMO Pharmaceuticals SA asset resilience ratio. COSMO Pharmaceuticals SA (COPN) has an Asset Resilience Ratio of 10.92% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See COPN cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CHF66.84 Million

≈ $84.51 Million USD Cash + Short-term Investments

Total Assets

CHF612.16 Million

≈ $773.93 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio of COSMO Pharmaceuticals SA (2009–2025)

Asset resilience ratio of COSMO Pharmaceuticals SA from 2009 to 2025. This chart shows how COSMO Pharmaceuticals SA's Asset Resilience Ratio has changed over time. Read total liabilities of COSMO Pharmaceuticals SA for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down COSMO Pharmaceuticals SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of COSMO Pharmaceuticals SA.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CHF0.00	0%
Short-term Investments	CHF66.84 Million	10.92%
Total Liquid Assets	CHF66.84 Million	10.92%

Asset Resilience Insights

Moderate Liquidity: COSMO Pharmaceuticals SA has 10.92% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

COSMO Pharmaceuticals SA Industry Peers by Asset Resilience Ratio

Compare COSMO Pharmaceuticals SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
AstraZeneca PLC NASDAQ:AZN	Drug Manufacturers - General	0.10%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.33%
Cosmo Pharmaceuticals N.V F:C43	Drug Manufacturers - General	10.92%
Zhejiang Int'L Group Co Ltd SHE:000411	Drug Manufacturers - General	0.00%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	6.46%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	6.34%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	Drug Manufacturers - General	17.40%

COSMO Pharmaceuticals SA Asset Resilience Ratio by Year (2009–2025)

COSMO Pharmaceuticals SA asset resilience ratio by year from 2009 to 2025. The table below shows the annual Asset Resilience Ratio data for COSMO Pharmaceuticals SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	10.92%	CHF66.84 Million ≈ $84.51 Million	CHF612.16 Million ≈ $773.93 Million	-4.34pp
2024-12-31	15.26%	CHF98.67 Million ≈ $124.74 Million	CHF646.77 Million ≈ $817.69 Million	--
2023-12-31	0.00%	CHF0.00 ≈ $0.00	CHF553.98 Million ≈ $700.38 Million	--
2022-12-31	7.26%	CHF55.13 Million ≈ $69.70 Million	CHF759.59 Million ≈ $960.33 Million	+4.32pp
2021-12-31	2.94%	CHF23.65 Million ≈ $29.90 Million	CHF805.56 Million ≈ $1.02 Billion	-1.58pp
2020-12-31	4.51%	CHF26.91 Million ≈ $34.03 Million	CHF596.16 Million ≈ $753.71 Million	-22.46pp
2019-12-31	26.97%	CHF157.82 Million ≈ $199.53 Million	CHF585.16 Million ≈ $739.80 Million	+4.80pp
2018-12-31	22.18%	CHF138.75 Million ≈ $175.41 Million	CHF625.69 Million ≈ $791.04 Million	+16.60pp
2017-12-31	5.57%	CHF27.76 Million ≈ $35.09 Million	CHF497.97 Million ≈ $629.57 Million	-5.44pp
2016-12-31	11.01%	CHF48.84 Million ≈ $61.74 Million	CHF443.47 Million ≈ $560.67 Million	+0.72pp
2015-12-31	10.29%	CHF45.06 Million ≈ $56.97 Million	CHF437.94 Million ≈ $553.68 Million	-0.94pp
2014-12-31	11.23%	CHF25.33 Million ≈ $32.02 Million	CHF225.62 Million ≈ $285.25 Million	-38.91pp
2013-12-31	50.13%	CHF121.82 Million ≈ $154.02 Million	CHF243.00 Million ≈ $307.22 Million	+50.13pp
2012-12-31	0.00%	CHF1.00 ≈ $1.26	CHF151.84 Million ≈ $191.97 Million	-0.11pp
2010-12-31	0.11%	CHF101.00K ≈ $127.69K	CHF91.83 Million ≈ $116.09 Million	-0.08pp
2009-12-31	0.19%	CHF139.00K ≈ $175.73K	CHF71.46 Million ≈ $90.35 Million	--

pp = percentage points

About COSMO Pharmaceuticals SA

SW:COPN Switzerland Drug Manufacturers - General

Market Cap

$1.27 Billion

CHF1.01 Billion CHF

Market Cap Rank

#7622 Global

#112 in Switzerland

Share Price

CHF58.70

Change (1 day)

-2.17%

52-Week Range

CHF58.40 - CHF124.80

All Time High

CHF171.24